JPRN-UMIN000008878已完成未知
ShorT and OPtimal duration of Dual AntiPlatelet Therapy study - STOPDAPT
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 1,500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who have been implanted drug eluting stent other than everolimus-eluting cobalt-chromium stent.
研究者
相似试验
进行中（未招募）
4 期
ShorT and OPtimal duration of Dual AntiPlatelet Therapy-3 studyIschemic heart disease, stable angina, myocardial infarctionJPRN-jRCTs052200114Ono Koh6,000
进行中（未招募）
4 期
ShorT and OPtimal duration of Dual AntiPlatelet Therapy-2 study for patients with ACSJPRN-jRCTs052180193Ono Koh3,000
进行中（未招募）
1 期
Optimal duration of dual anti-platelet therapy in patients undergoing endovascular revascularization of the superficial femoral artery.Patients with diagnosis of lower limbs PAOD, ranging from stage 2 to 5 according to Rutherford classification and lesions of the SFA treated by endovascular revascularizationMedDRA version: 20.0Level: LLTClassification code 10016430Term: Femoral artery stenosisSystem Organ Class: 100000004866EUCTR2018-000532-94-ITFONDAZIONE I.R.C.C.S. POLICLINICO SAN MATTEO78
进行中（未招募）
不适用
Optimal duration of dual antiplatelet therapy after stent-assisted coiling of unruptured intracranial aneurysms: A prospective randomized multicenter trialDiseases of the circulatory systemKCT0006651Seoul National University Bundang Hospital528
招募中
不适用
DURATIODiseases of the circulatory systemKCT0004407Seoul National University Bundang Hospital4,748